Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial
Condition: Multidrug Resistant Tuberculosis Interventions: Drug: Bedaquiline; Drug: Pretomanid; Drug: Moxifloxacin; Drug: Linezolid; Drug: Clofazimine; Drug: Directly observed therapy (DOT) Sponsors: Medecins Sans Frontieres, Netherlands; University of Sussex; London School of Hygiene and Tropical Medicine; Doris Goodwin Hospitals, Kwazulu Natal, South Africa; Don McKenzie Hospitals, Kwazulu Natal, South Africa; Republican Scientific and Practical Centre for Pulmono logy and Tuberculosis hospital; Republican specialised scientific-practical medical centre, Tashkent; Republican TB Hospital No. 2, Nukus Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | Avelox | Bedaquiline | Clinical Trials | Hospitals | Linezolid | Moxifloxacin | Netherlands Health | Research | South Africa Health | Tuberculosis | Zyvox